McGlone Suttner Wealth Management Inc. Acquires 1,271 Shares of MetLife, Inc. (NYSE:MET)

McGlone Suttner Wealth Management Inc. increased its holdings in MetLife, Inc. (NYSE:METFree Report) by 11.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 12,182 shares of the financial services provider’s stock after purchasing an additional 1,271 shares during the quarter. McGlone Suttner Wealth Management Inc.’s holdings in MetLife were worth $806,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of the business. Navalign LLC grew its stake in shares of MetLife by 4.0% in the fourth quarter. Navalign LLC now owns 10,940 shares of the financial services provider’s stock worth $723,000 after purchasing an additional 423 shares during the last quarter. SeaCrest Wealth Management LLC boosted its position in MetLife by 5.0% during the fourth quarter. SeaCrest Wealth Management LLC now owns 7,827 shares of the financial services provider’s stock valued at $539,000 after acquiring an additional 375 shares during the last quarter. Uncommon Cents Investing LLC boosted its position in MetLife by 5.1% during the fourth quarter. Uncommon Cents Investing LLC now owns 17,399 shares of the financial services provider’s stock valued at $1,151,000 after acquiring an additional 849 shares during the last quarter. Austin Private Wealth LLC boosted its position in MetLife by 4.1% during the fourth quarter. Austin Private Wealth LLC now owns 4,367 shares of the financial services provider’s stock valued at $289,000 after acquiring an additional 170 shares during the last quarter. Finally, WASHINGTON TRUST Co bought a new stake in MetLife during the fourth quarter valued at $41,000. Institutional investors own 89.81% of the company’s stock.

MetLife Stock Performance

Shares of MetLife stock traded up $0.19 on Thursday, reaching $74.11. 2,591,672 shares of the company traded hands, compared to its average volume of 3,777,516. MetLife, Inc. has a 52 week low of $48.95 and a 52 week high of $74.39. The company has a 50 day moving average of $69.88 and a 200 day moving average of $65.88. The firm has a market capitalization of $53.58 billion, a PE ratio of 40.50, a PEG ratio of 0.55 and a beta of 1.03. The company has a debt-to-equity ratio of 0.53, a current ratio of 0.16 and a quick ratio of 0.16.

MetLife (NYSE:METGet Free Report) last released its earnings results on Wednesday, January 31st. The financial services provider reported $1.93 earnings per share for the quarter, missing analysts’ consensus estimates of $1.95 by ($0.02). MetLife had a net margin of 2.36% and a return on equity of 19.48%. The company had revenue of $18.72 billion for the quarter, compared to the consensus estimate of $18.07 billion. Equities analysts forecast that MetLife, Inc. will post 8.81 earnings per share for the current year.

MetLife Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, March 14th. Investors of record on Tuesday, February 6th were issued a $0.52 dividend. This represents a $2.08 annualized dividend and a yield of 2.81%. The ex-dividend date was Monday, February 5th. MetLife’s dividend payout ratio (DPR) is presently 113.66%.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the stock. Wells Fargo & Company dropped their price objective on shares of MetLife from $85.00 to $83.00 and set an “overweight” rating on the stock in a report on Tuesday, February 6th. Keefe, Bruyette & Woods dropped their price objective on shares of MetLife from $79.00 to $77.00 and set an “outperform” rating on the stock in a report on Thursday, December 7th. The Goldman Sachs Group upgraded shares of MetLife from a “neutral” rating to a “buy” rating and upped their price objective for the company from $70.00 to $80.00 in a report on Monday, January 8th. Finally, UBS Group dropped their price objective on shares of MetLife from $87.00 to $82.00 and set a “buy” rating on the stock in a report on Monday, February 5th. Two analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat.com, MetLife currently has a consensus rating of “Moderate Buy” and a consensus target price of $77.23.

Get Our Latest Report on MET

Insider Buying and Selling

In related news, insider Ramy Tadros sold 4,026 shares of the firm’s stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $71.90, for a total value of $289,469.40. Following the completion of the transaction, the insider now directly owns 146,981 shares of the company’s stock, valued at approximately $10,567,933.90. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In other MetLife news, insider Ramy Tadros sold 4,026 shares of the stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $71.90, for a total value of $289,469.40. Following the sale, the insider now directly owns 146,981 shares in the company, valued at approximately $10,567,933.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Bill Pappas sold 27,000 shares of the stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $72.27, for a total transaction of $1,951,290.00. Following the completion of the sale, the executive vice president now owns 57,768 shares in the company, valued at $4,174,893.36. The disclosure for this sale can be found here. 0.32% of the stock is owned by insiders.

MetLife Company Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Recommended Stories

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.